{"transactions":[{"id":746227,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T20:54:08.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":4310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date."}],"balance_after":4310,"derivative":{"exercise_price":45.33,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":4310},"source":{"system":"sec-edgar","filing":"0001104659-26-071429","document":"tm2617049-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926071429/tm2617049-5_4seq1.xml","form_type":"4"}},{"id":746226,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T20:54:08.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":6839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 15,057 shares of common stock and 6,839 RSUs."}],"balance_after":21896,"source":{"system":"sec-edgar","filing":"0001104659-26-071429","document":"tm2617049-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926071429/tm2617049-5_4seq1.xml","form_type":"4"}},{"id":1129299,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T20:31:05.000Z","date":"2025-05-29","kind":"sale","planned":true,"acquired":false,"shares":1400,"price":30.0031,"value":42004.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025 to cover tax withholding obligations upon the vesting and settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.91 to $30.10, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of 7,425 shares of common stock and 7,632 RSUs."}],"balance_after":15057,"source":{"system":"sec-edgar","filing":"0001415889-25-015003","document":"form4-05302025_040508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588925015003/form4-05302025_040508.xml","form_type":"4"}},{"id":1129298,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T20:31:05.000Z","date":"2025-05-29","kind":"sale","planned":true,"acquired":false,"shares":4675,"price":29.6313,"value":138526.3275,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025 to cover tax withholding obligations upon the vesting and settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.90 to $29.89, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of 8,825 shares of common stock and 7,632 RSUs."}],"balance_after":16457,"source":{"system":"sec-edgar","filing":"0001415889-25-015003","document":"form4-05302025_040508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588925015003/form4-05302025_040508.xml","form_type":"4"}},{"id":1135421,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:47:23.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":9206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."}],"balance_after":9206,"derivative":{"exercise_price":30.46,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":9206},"source":{"system":"sec-edgar","filing":"0001104659-25-052483","document":"tm2516084-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465925052483/tm2516084-7_4seq1.xml","form_type":"4"}},{"id":1135420,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T20:47:23.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":7632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2026 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 13,500 shares of Common Stock and 7,632 RSUs."}],"balance_after":21132,"source":{"system":"sec-edgar","filing":"0001104659-25-052483","document":"tm2516084-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465925052483/tm2516084-7_4seq1.xml","form_type":"4"}},{"id":1137481,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-22T20:22:45.000Z","date":"2025-05-20","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.1895,"value":23790.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001894562-25-000030","document":"wk-form4_1747945354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000030/wk-form4_1747945354.xml","form_type":"4"}},{"id":1236181,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T01:12:36.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.42,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001894562-25-000004","document":"wk-form4_1741050750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000004/wk-form4_1741050750.xml","form_type":"4"}},{"id":1339186,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-09T23:22:59.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":19300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option initially granted to the Reporting Person on August 4, 2022, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On December 5, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 19,300 shares."}],"balance_after":57900,"derivative":{"exercise_price":7.96,"expiration_date":"2032-08-04","underlying":"Common Stock","underlying_shares":19300},"source":{"system":"sec-edgar","filing":"0001894562-24-000048","document":"wk-form4_1733786573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000048/wk-form4_1733786573.xml","form_type":"4"}},{"id":1465842,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T21:15:34.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."}],"balance_after":18000,"derivative":{"exercise_price":8.36,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001415889-24-018631","document":"form4-07012024_090731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588924018631/form4-07012024_090731.xml","form_type":"4"}},{"id":1465841,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T21:15:34.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest  on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 13,500 RSUs."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001415889-24-018631","document":"form4-07012024_090731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588924018631/form4-07012024_090731.xml","form_type":"4"}},{"id":1507354,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-21T20:11:10.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":19300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option initially granted to the Reporting Person on August 4, 2022, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On May 17, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 19,300 shares."}],"balance_after":38600,"derivative":{"exercise_price":7.96,"expiration_date":"2032-08-04","underlying":"Common Stock","underlying_shares":19300},"source":{"system":"sec-edgar","filing":"0001894562-24-000023","document":"wk-form4_1716322256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000023/wk-form4_1716322256.xml","form_type":"4"}},{"id":1622886,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-23T22:04:17.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":135747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 21, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":135747,"derivative":{"exercise_price":8.49,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":135747},"source":{"system":"sec-edgar","filing":"0001894562-24-000014","document":"wk-form4_1708725818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000014/wk-form4_1708725818.xml","form_type":"4"}},{"id":1922303,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-10T20:31:36.000Z","date":"2023-04-06","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such options shall vest in equal monthly installments during the three year period following the Transaction Date; so long as such individual continues to serve as a member of the Corporation's Board of Directors on such date."}],"balance_after":56000,"derivative":{"exercise_price":7.85,"expiration_date":"2033-04-06","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001415889-23-006405","document":"form4-04102023_080426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588923006405/form4-04102023_080426.xml","form_type":"4"}},{"id":1929025,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-05T00:22:55.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":135747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":135747,"derivative":{"exercise_price":12.3,"expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":135747},"source":{"system":"sec-edgar","filing":"0001894562-23-000004","document":"wf-form4_168065416536123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456223000004/wf-form4_168065416536123.xml","form_type":"4"}},{"id":2055284,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-13T21:03:54.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":27936,"source":{"system":"sec-edgar","filing":"0001477932-23-000275","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223000275/form4.xml","form_type":"4"}},{"id":2137424,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T20:06:36.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":22311,"source":{"system":"sec-edgar","filing":"0001477932-22-007699","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007699/form4.xml","form_type":"4"}},{"id":2222611,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:05:52.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":5613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 5,613 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 2,807 shares and 2,806 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 3,022 shares subject to the award previously vested and remain subject to time-based vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 5,613 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 2,807 shares and 2,806 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 3,022 shares subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":8635,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":5613},"source":{"system":"sec-edgar","filing":"0001477932-22-004666","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004666/form4.xml","form_type":"4"}},{"id":2222610,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:05:52.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":3046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 4,686 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 3,046 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 1,523 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in April 2022, the rights with respect to the remaining 1,640 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":19686,"source":{"system":"sec-edgar","filing":"0001477932-22-004666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004666/form4.xml","form_type":"4"}},{"id":2300882,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:02:26.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":3022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 3,022 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 1,511 shares on each of August 3, 2022 and August 3, 2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 3,022 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 1,511 shares on each of August 3, 2022 and August 3, 2023, respectively."}],"balance_after":3022,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":3022},"source":{"system":"sec-edgar","filing":"0001477932-22-002178","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002178/form4.xml","form_type":"4"}},{"id":2300881,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T20:02:26.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":1640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 4,686 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 1,640 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 820 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":16640,"source":{"system":"sec-edgar","filing":"0001477932-22-002178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002178/form4.xml","form_type":"4"}},{"id":2385477,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-02-18T21:05:57.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":16275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 16, 2022, the reporting person was granted 16,275 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 16, 2022, the reporting person was granted 16,275 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."}],"balance_after":16275,"derivative":{"underlying":"Common Stock","underlying_shares":16275},"source":{"system":"sec-edgar","filing":"0000899243-22-007015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000089924322007015/doc4.xml","form_type":"4"}},{"id":2385476,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-18T21:05:57.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":10850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":10850,"derivative":{"exercise_price":5.21,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":10850},"source":{"system":"sec-edgar","filing":"0000899243-22-007015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000089924322007015/doc4.xml","form_type":"4"}},{"id":2428778,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-01-21T21:06:02.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 19, 2022, the reporting person was granted 8,400 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 19, 2022, the reporting person was granted 8,400 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":8400,"derivative":{"underlying":"Common Stock","underlying_shares":8400},"source":{"system":"sec-edgar","filing":"0000899243-22-002870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000089924322002870/doc4.xml","form_type":"4"}},{"id":2428777,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-21T21:06:02.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":41000,"derivative":{"exercise_price":7.21,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0000899243-22-002870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000089924322002870/doc4.xml","form_type":"4"}},{"id":2770117,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-29T20:39:46.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Brudnick received restricted stock units subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 03/25/22 and 03/25/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001078782-21-000282","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878221000282/primary_doc.xml","form_type":"4"}},{"id":2895239,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T21:51:32.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 22, 2022, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":31000,"derivative":{"exercise_price":26.6,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0000899243-21-003316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000089924321003316/doc4.xml","form_type":"4"}},{"id":4005867,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2018-03-08T16:25:06.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":59595,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":44.51,"underlying":"Common Stock","underlying_shares":59595},"source":{"system":"sec-edgar","filing":"0001127602-18-010636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218010636/form4.xml","form_type":"4"}},{"id":4005866,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2018-03-08T16:25:06.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":29797,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":44.51,"underlying":"Common Stock","underlying_shares":29797},"source":{"system":"sec-edgar","filing":"0001127602-18-010636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218010636/form4.xml","form_type":"4"}},{"id":4005865,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2018-03-08T16:25:06.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":14899,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":44.51,"underlying":"Common Stock","underlying_shares":14899},"source":{"system":"sec-edgar","filing":"0001127602-18-010636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218010636/form4.xml","form_type":"4"}},{"id":4005864,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Restricted Stock Units","published_at":"2018-03-08T16:25:06.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":31818,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31818},"source":{"system":"sec-edgar","filing":"0001127602-18-010636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218010636/form4.xml","form_type":"4"}},{"id":4005863,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Restricted Stock Units","published_at":"2018-03-08T16:25:06.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7489,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7489},"source":{"system":"sec-edgar","filing":"0001127602-18-010636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218010636/form4.xml","form_type":"4"}},{"id":4005862,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2018-03-08T16:25:06.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":22952,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 4,911 shares subject to restricted stock units.  See also note 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of January 21, 2018 (the \"Merger Agreement\"), between the Company, Sanofi, a French soci?t? anonyme (the \"Parent\"), and Blink Acquisition Corp. (\"Merger Sub\"), on March 8, 2018, Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\").  Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive $105.00 in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-18-010636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218010636/form4.xml","form_type":"4"}},{"id":4034132,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2018-02-26T22:04:06.000Z","date":"2018-02-23","kind":"tax_withholding","acquired":false,"shares":924,"price":104.74,"value":96779.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":22952,"source":{"system":"sec-edgar","filing":"0001127602-18-008433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218008433/form4.xml","form_type":"4"}},{"id":4034131,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2018-02-26T22:04:06.000Z","date":"2018-02-22","kind":"tax_withholding","acquired":false,"shares":1419,"price":104.3,"value":148001.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":23876,"source":{"system":"sec-edgar","filing":"0001127602-18-008433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218008433/form4.xml","form_type":"4"}},{"id":4055161,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Restricted Stock Units","published_at":"2018-02-15T22:06:53.000Z","date":"2018-02-14","kind":"exercise","acquired":false,"shares":3744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."}],"balance_after":7489,"derivative":{"underlying":"Common Stock","underlying_shares":3744},"source":{"system":"sec-edgar","filing":"0001127602-18-006421","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218006421/form4.xml","form_type":"4"}},{"id":4055160,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2018-02-15T22:06:53.000Z","date":"2018-02-14","kind":"tax_withholding","acquired":false,"shares":1137,"price":103.52,"value":117702.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":25295,"source":{"system":"sec-edgar","filing":"0001127602-18-006421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218006421/form4.xml","form_type":"4"}},{"id":4055159,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2018-02-15T22:06:53.000Z","date":"2018-02-14","kind":"exercise","acquired":true,"shares":3744,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26432,"source":{"system":"sec-edgar","filing":"0001127602-18-006421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218006421/form4.xml","form_type":"4"}},{"id":4079375,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Restricted Stock Units","published_at":"2018-02-02T22:09:51.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":31818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning on January 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning on January 31, 2019."}],"balance_after":31818,"derivative":{"underlying":"Common Stock","underlying_shares":31818},"source":{"system":"sec-edgar","filing":"0001127602-18-003804","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760218003804/form4.xml","form_type":"4"}},{"id":4371637,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2017-03-27T20:24:12.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":14899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning on February 14, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."}],"balance_after":14899,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":14899},"source":{"system":"sec-edgar","filing":"0001127602-17-012944","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217012944/form4a.xml","form_type":"4/A","original_submission_date":"2017-02-16"}},{"id":4371636,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2017-03-27T20:24:12.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":59595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the third anniversary of the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."}],"balance_after":59595,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":59595},"source":{"system":"sec-edgar","filing":"0001127602-17-012944","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217012944/form4a.xml","form_type":"4/A","original_submission_date":"2017-02-16"}},{"id":4371635,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2017-03-27T20:24:12.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":29797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning on February 14, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing."}],"balance_after":29797,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":29797},"source":{"system":"sec-edgar","filing":"0001127602-17-012944","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217012944/form4a.xml","form_type":"4/A","original_submission_date":"2017-02-16"}},{"id":4409902,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":1100,"price":43.42,"value":47762.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":22688,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409901,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":66,"price":43.42,"value":2865.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":23788,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409900,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":681,"price":47.76,"value":32524.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":23854,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409899,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":339,"price":49.56,"value":16800.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":24535,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409898,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":429,"price":43.42,"value":18627.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":24874,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409897,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":25,"price":43.42,"value":1085.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":25303,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409896,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":837,"price":47.76,"value":39975.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":25328,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409895,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":411,"price":49.56,"value":20369.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":26165,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409894,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":939,"price":43.42,"value":40771.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":26576,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409893,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":45,"price":47.76,"value":2149.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":27515,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409892,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":22,"price":49.56,"value":1090.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":27560,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409891,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":51,"price":43.42,"value":2214.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units."}],"balance_after":27582,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4409890,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-02T21:06:43.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":27376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes restricted stock units granted by Bioverativ Inc. (\"Bioverativ\") to the reporting person as a result of the conversion of existing Biogen Inc. (\"Biogen\") cash-settled performance units and market stock units held by the reporting person prior to the spin-off of Bioverativ from Biogen on February 1, 2017 (\"Spin-Off\"), as set forth in an employee matters agreement entered into between Bioverativ and Biogen in connection with the Spin-Off.  Restricted stock units that are unvested continue to vest on the dates of the original Biogen awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 257 shares acquired in a pro rata distribution by Biogen in connection with the Spin-Off."}],"balance_after":27633,"source":{"system":"sec-edgar","filing":"0001127602-17-009668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217009668/form4.xml","form_type":"4"}},{"id":4442785,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2017-02-16T21:39:36.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":14872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments beginning on February 14, 2018."}],"balance_after":14872,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":14872},"source":{"system":"sec-edgar","filing":"0001127602-17-006618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217006618/form4.xml","form_type":"4"}},{"id":4442784,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2017-02-16T21:39:36.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":59488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in full on the third anniversary of the date of grant."}],"balance_after":59488,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":59488},"source":{"system":"sec-edgar","filing":"0001127602-17-006618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217006618/form4.xml","form_type":"4"}},{"id":4442783,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Restricted Stock Units","published_at":"2017-02-16T21:39:36.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":11233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on February 14, 2018."}],"balance_after":11233,"derivative":{"underlying":"Common Stock","underlying_shares":11233},"source":{"system":"sec-edgar","filing":"0001127602-17-006618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217006618/form4.xml","form_type":"4"}},{"id":4442782,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":40496,"kind":"person","name":"Brudnick Richard","position":1,"cik":"0001692359","reported_name":"Brudnick Richard","relationship":{"officer":true,"officer_title":"EVP, Business Development"}}],"security":"Non-Qualified Stock Option","published_at":"2017-02-16T21:39:36.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":29744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments beginning on February 14, 2018."}],"balance_after":29744,"derivative":{"exercise_price":44.51,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":29744},"source":{"system":"sec-edgar","filing":"0001127602-17-006618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692359/000112760217006618/form4.xml","form_type":"4"}}]}